Catalyst Event
Johnson & Johnson (JNJ) · Other
From KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index (KUSDV100P)
3/19/2026, 12:00:00 AM
A new group litigation claim was launched in Scotland on March 19, 2026, against Johnson & Johnson regarding its talc products, adding to the tens of thousands of ongoing lawsuits in the U.S. alleging links to cancer.
Korean Translation
2026년 3월 19일, 존슨앤드존슨의 활석 제품과 관련하여 스코틀랜드에서 새로운 집단 소송이 제기되었으며, 이는 암 유발 혐의로 미국에서 진행 중인 수만 건의 소송에 더해진 것임
Related Recent Events
Target Corp (TGT) · Earnings Release
Q1 2026 earnings release scheduled for 2026-05-20 scheduled.
5/20/2026, 12:00:00 AM
Amgen Inc (AMGN) · Other
A quarterly dividend of $2.52 per share for Q2 2026 is scheduled, with an ex-dividend date of May 15, 2026; a price impact of ≥1% is estimated due to the routine nature of the distribution, scheduled.
5/15/2026, 12:00:00 AM
Williams Cos Inc. (The) (WMB) · Earnings Release
Q1 2026 earnings release is scheduled for 2026-05-04. Earnings releases typically result in a price impact of at least 5%. Analysts forecast EPS of approximately $0.62-$0.63 forecasted.
5/4/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Earnings Release
Merck is scheduled to release its Q1 2026 financial results before the market opens. Earnings releases typically cause significant price volatility, justifying a Medium importance, scheduled.
4/30/2026, 12:00:00 AM
Conocophillips (COP) · Earnings Release
First quarter 2026 earnings release and conference call scheduled for April 30, 2026; ≥1% price impact estimated upon release, scheduled.
4/30/2026, 12:00:00 AM
United Parcel Service Inc (UPS) · Earnings Release
Q1 2026 earnings release scheduled. Medium importance is assigned as earnings releases typically cause price volatility exceeding 5%.
4/28/2026, 12:00:00 AM